Multiple Mechanisms Underlie Resistance of Leukemia Cells to Apo2 Ligand/Trail

Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-06-0050
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)